TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both?

Dig Dis Sci. 2019 Jun;64(6):1432-1435. doi: 10.1007/s10620-018-5334-7.

Authors

Miquell Miller¹, Kim-Nhien Vu², Allison Zemek³, Andrew Shelton⁴, Cindy Kin⁴

Affiliations

¹ Colorectal Surgery, Division of General Surgery, Stanford University School of Medicine, 300 Pasteur Drive. H3691, Stanford, CA, 94305, USA. [email protected].
² Department of Radiology, Stanford University School of Medicine, 300 Pasteur Drive., Stanford, CA, 94305, USA.
³ Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive. H2210, Stanford, CA, 94305, USA.
⁴ Colorectal Surgery, Division of General Surgery, Stanford University School of Medicine, 300 Pasteur Drive. H3691, Stanford, CA, 94305, USA.

PMID: 30334111
DOI: 10.1007/s10620-018-5334-7

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Inflammatory Agents / adverse effects
Antitubercular Agents / therapeutic use
Clinical Decision-Making
Crohn Disease / diagnosis*
Crohn Disease / drug therapy
Crohn Disease / immunology
Diagnosis, Differential
Female
Gastrointestinal Agents / adverse effects
Humans
Immunocompromised Host
Latent Tuberculosis / diagnosis*
Latent Tuberculosis / drug therapy
Latent Tuberculosis / immunology
Latent Tuberculosis / microbiology
Peritonitis, Tuberculous / diagnosis*
Peritonitis, Tuberculous / drug therapy
Peritonitis, Tuberculous / immunology
Peritonitis, Tuberculous / microbiology
Risk Factors
Treatment Outcome

Substances

Anti-Inflammatory Agents
Antitubercular Agents
Gastrointestinal Agents